Home > News > OTC Stock Review
July 19th, 2005
OTC Stock Review
Abstract:
Shares of BIPH closed at $2.65 on Monday on volume of 683,343 shares. Our recent alert adding BIPH to our watch list indicated that April 4, 2005, three months before Boston Scientific paid a premium to buy $5 million worth of Biophan's shares, Beacon Equity Research issued a report with a price target of $5.17
Source:
primezone.com
Bookmark:
| Related News Press |
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Financial Reports
Arrowhead Pharmaceuticals to Webcast Fiscal 2021 Second Quarter Results April 16th, 2021
Arrowhead Pharmaceuticals to Webcast Fiscal 2021 Second Quarter Results April 16th, 2021
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||